Bruker Corporation
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000CL1FG7
BRKR
Bruker Corporation
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Devices
NAME
Bruker Corporation
ISIN
US1167941087
TICKER
BRKR
MIC
XNAS
REUTERS
BRKR.OQ
BLOOMBERG
BRKR US
F&G:
59
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Tue, 03.06.2025
Bruker
US1167941087
Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker’s continued investment in applied marke...
Tue, 03.06.2025
Bruker
US1167941087
Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603323690/en/biocrates kits and pipettes
biocrates is a global leader in...
Mon, 02.06.2025
Bruker
US1167941087
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significant further advances in ultra-high sensitivity 4D-Proteomics™ with the introduction of the timsUltra AIP mass spectrometer. Its innovative, breakthrough Athena Ion Processor (AIP) technology further boosts the extreme sen...
Mon, 02.06.2025
Bruker
US1167941087
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteom...
Fri, 30.05.2025
Bruker
US1167941087
Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time.
A live audio webcast of the presentation will be available on the Investor Relations sectio...
Fri, 30.05.2025
Bruker
US1167941087
For the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) announced the launch of the timsOmni™ system, a transformative new timsTOF-based mass spectrometer designed for scientific, drug discovery, and clinical researchers, as well as for advanced QC on biologics, offering deep structural insights int...
Fri, 30.05.2025
Bruker
US1167941087
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) launched timsMetabo, a peak-performance 4D-Metabolomics™ mass spectrometer delivering unprecedented sensitivity, separation power and annotation confidence for small molecules, further enhanced by the novel TIMS ‘MoRE’ scan-mode. The timsMetabo ...
Wed, 28.05.2025
Bruker
US1167941087
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the MOVE-T, a state-of-the-art liquid dairy analyzer designed to elevate quality control standards in the dairy industry. Utilizing advanced Fourier Transform Near-Infrared (FT-NIR) technology, the MOVE-T provides unparalleled precision analyzing raw milk and other liquid dairy produc...
Thu, 15.05.2025
Bruker
US1167941087
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on June 27, 2025 to stockholders of record as of June 16, 2025.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq:...
Wed, 14.05.2025
Bruker
US1167941087
Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both...
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
